Amphastar Pharmaceuticals AMPH Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.42M-73.7% | $24.43M+40.8% | $17.35M-44.1% | $31.03M+22.7% | $25.29M-33.4% | ||
| $8.08M+0.1% | $8.07M+2.7% | $7.86M-5.8% | $8.35M+13.3% | $7.37M+1.5% | ||
| $9.27M+49.5% | $6.21M-1.5% | $6.3M-1.3% | $6.38M-24.0% | $8.39M+49.0% | ||
| $761K-12.1% | $866K-2.1% | $885K+5.1% | $842K+10.5% | $762K+5.2% | ||
| -$4K+33.3% | -$6K-500% | -$1K+96.7% | -$30K-1,400% | -$2K— | ||
| $4.55M— | —— | $13.79M+212% | -$12.27M-252% | $8.08M— | ||
| -$6.25M— | —— | —— | $4.82M-84.5% | $31.11M+27.1% | ||
| $9.6M+123% | -$42.64M-268% | $25.34M+622% | -$4.86M-128% | $17.61M+734% | ||
| $2.33M— | —— | $7.94M+73.8% | $4.57M+438% | $849K+258% | ||
| $6.27M0.0% | $6.27M0.0% | $6.27M0.0% | $6.27M+0.5% | $6.24M+1.0% | ||
| $2.14M+30.3% | $1.65M+0.4% | $1.64M+1.0% | $1.62M+1.6% | $1.6M+30.1% | ||
| $47.84M+45.6% | $32.86M-37.5% | $52.58M+47.7% | $35.59M+1.5% | $35.08M+20.9% | ||
| $9.51M+14.9% | $8.27M+54.7% | $5.35M-49.4% | $10.57M-1.2% | $10.7M-13.8% | ||
| -$16.73M+72.4% | -$60.57M-209% | -$19.62M-3,039% | -$625K-106% | $10.48M+129% | ||
| $29.49M+43.8% | $20.52M+323% | $4.85M-87.6% | $39.22M+257% | $11M-73.8% | ||
| —— | —— | $172K-95.8% | $4.13M+151% | $1.64M— | ||
| $29K-72.1% | $104K+136% | $44K+18.9% | $37K-2.6% | $38K-67.0% | ||
| —— | $8K+100% | $4K-98.4% | $253K-40.0% | $422K— | ||
| -$30.21M-64.4% | -$18.37M-323% | -$4.35M+85.6% | -$30.2M-108% | -$14.5M+57.1% | ||
| -$138K— | —— | —— | $142K+20.3% | $118K+1,173% | ||
| $762K— | —— | $28.58M+482% | $4.91M-84.3% | $31.17M— | ||
| $7.3M+78.8% | $4.08M-45.3% | $7.47M+82.5% | $4.09M-46.1% | $7.58M+71.5% | ||
| -$4.11M-1,123% | $402K+3,920% | $10K-100.0% | $23.2M+2,672% | -$902K-108% | ||
| $761K— | —— | —— | —— | $762K— | ||
| $6.27M0.0% | $6.27M0.0% | $6.27M0.0% | $6.27M+0.5% | $6.24M+1.0% | ||
| $8.08M+0.1% | $8.07M+2.7% | $7.86M-5.8% | $8.35M+13.3% | $7.37M+1.5% | ||
| -$4K+33.3% | -$6K-500% | -$1K+96.7% | -$30K-1,400% | -$2K— | ||
| -$7.74M-138% | $20.5M— | —— | $14.94M+331% | -$6.47M+46.0% | ||
| $2.33M— | —— | $7.94M+73.8% | $4.57M+438% | $849K+258% | ||
| $2.14M+30.3% | $1.65M+0.4% | $1.64M+1.0% | $1.62M+1.6% | $1.6M+30.1% | ||
| -$1.42M+14.6% | -$1.66M-4.1% | -$1.59M+1.1% | -$1.61M-113% | -$754K+14.7% | ||
| —— | $8K+100% | $4K-98.4% | $253K-40.0% | $422K— | ||
| $4.17M+244% | $1.21M+156% | $474K— | —— | $7.22M+1,338% | ||
| $416K— | —— | —— | —— | -$2.14M— | ||
| $30.71M— | —— | $2.02M— | —— | $521K-96.8% | ||
| -$67K-115% | $434K-72.7% | $1.59M-31.3% | $2.32M+12,772% | $18K-98.8% | ||
| $686K— | —— | —— | —— | $4.69M— | ||
| -$4.11M— | —— | —— | —— | -$902K— | ||
| $38.33M+55.9% | $24.59M-47.9% | $47.24M+88.7% | $25.03M+2.7% | $24.38M+46.8% | ||
| $38.33M+55.9% | $24.59M-47.9% | $47.24M+88.7% | $25.03M+2.7% | $24.38M+46.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Amphastar Pharmaceuticals generate?
- Amphastar Pharmaceuticals (AMPH) generated $168.9M in operating cash flow over the trailing twelve months.
- What is Amphastar Pharmaceuticals's free cash flow?
- After $33.7M of capital expenditures, Amphastar Pharmaceuticals's free cash flow was $135.2M over the trailing twelve months, down 10.0% year over year.
- Where does Amphastar Pharmaceuticals's cash flow data come from?
- Every line is extracted from Amphastar Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
